- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 251/40 - Nitrogen atoms
Patent holdings for IPC class C07D 251/40
Total number of patents in this class: 30
10-year publication summary
|
1
|
3
|
1
|
0
|
2
|
5
|
2
|
2
|
1
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 379 |
2 |
| Musc Foundation for Research Development | 369 |
2 |
| Pacific Biosciences of California, Inc. | 692 |
2 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 719 |
2 |
| University of South Alabama | 133 |
2 |
| Shanghai Hansoh Biomedical Co., Ltd. | 360 |
2 |
| The Regents of the University of California | 20815 |
1 |
| Merck Patent GmbH | 5735 |
1 |
| Board of Regents, The University of Texas System | 6141 |
1 |
| Archroma IP GmbH | 461 |
1 |
| Astellas Pharma Inc. | 1039 |
1 |
| The Charlotte-Mecklenburg Hospital Authority, DBA Carolinas HealthCare System | 84 |
1 |
| D.E. Shaw Research, LLC | 99 |
1 |
| Gowan Company, L.L.C. | 141 |
1 |
| Jiangsu Hengrui Medicine Co., Ltd. | 686 |
1 |
| Jiangsu Hengyi Pharmaceutical Co., Ltd. | 370 |
1 |
| Shinryo Corporation | 72 |
1 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3328 |
1 |
| Whitehead Institute for Biomedical Research | 327 |
1 |
| Canyon Group LLC | 3 |
1 |
| Other owners | 4 |